Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)
Clinical trial NCT00725842 · TERMINATED
Trial details
- NCT number
- NCT00725842
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-06-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.